home / stock / pti / pti news


PTI News and Press, Yumanity Therapeutics Inc Com From 12/16/19

Stock Information

Company Name: Yumanity Therapeutics Inc Com
Stock Symbol: PTI
Market: NASDAQ

Menu

PTI PTI Quote PTI Short PTI News PTI Articles PTI Message Board
Get PTI Alerts

News, Short Squeeze, Breakout and More Instantly...

PTI - Why Acadia And Proteostasis Were Among Our Top Names

Screen capture via Acadia's website . Acadia And Proteostasis: Risk On? Since June of 2017, I have presented my system's top 10 names to my Marketplace subscribers each week. So far, we have full six-month performance numbers for 106 of those top names cohorts, and they have outperforme...

PTI - Penny Stocks On Robinhood To Watch If You Work A Day Job

Penny Stocks Are Hard To Watch If You Work Full Time, But Some Trends Could Open Opportunities Let’s face it, penny stocks are tough to trade especially if you are working full-time. You might be able to dedicate a few minutes away from your desk to actually buy penny stocks. But when...

PTI - Why Pharmaceutical R&D Global Spending Could Exceed $200 Billion By 2024

December 11, 2019 Palm Beach, FL –December 11, 2019 – According to various industry and market publications, pharmaceutical companies spend, on average, 17% of revenues on R&D, making it one of the biggest spenders in this area. Outside of the semiconductor industry,...

PTI - SBGL, OLLI among premarket gainers

Camber Energy (NYSEMKT: CEI ) +40% . More news on: Camber Energy, Inc., My Size, Inc., Proteostasis Therapeutics, Inc., Stocks on the move, Read more ...

PTI - Proteostasis to initiate personalized CF study in Europe; shares up 17% premarket

Proteostasis Therapeutics (NASDAQ: PTI ) announces positive, initial ex-vivo results of its proprietary cystic fibrosis transmembrane conductance regulator (CFTR) modulators, PTI-801, PTI-808, and PTI-428, in individuals with cystic fibrosis (CF) who are ineligible for the current sta...

PTI - Proteostasis Therapeutics to Initiate First Ever Personalized Medicine-Based Clinical Trial, CHOICES, in European CF Patients with Genotypes Ineligible for Approved CFTR Modulators

BOSTON , Dec. 11, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced positive, initial ex-vivo results o...

PTI - Biotech's Year-End To-Do List

Before we ring in 2020, December will be ripe for swings in biotech stock prices. 2019 started strong, waned, and then regained momentum amid a slew of successful clinical trial results, several acquisition announcements, and positive drug approval decisions that came often months ahead of the U...

PTI - Can You Make Money With Penny Stocks? 3 Up Big In Q4

These Penny Stocks Are Up Big This Quarter One of the most important things to keep in mind with regards to penny stocks is that there’s potential to generate enormous returns from a very small investment. Therefore, investors are almost always on the lookout for penny stocks that h...

PTI - CLVS, AUPH, ESTC and HOV among midday movers

Gainers: Aurinia Pharmaceuticals (NASDAQ: AUPH ) +95% . More news on: Aurinia Pharmaceuticals Inc., Duluth Holdings Inc., Atreca, Inc., Stocks on the move, Read more ...

PTI - GPRO, CLVS among premarket gainers

Schmitt Industries (NASDAQ: SMIT ) +13%  on $2M stock repurchase plan . More news on: Schmitt Industries, Inc., EyePoint Pharmaceuticals, Inc., Kodiak Sciences Inc., Stocks on the move, Read more ...

Previous 10 Next 10